Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates
Dr. London is a global leader in veterinary targeted therapies. She discusses potential risks to veterinary staff, the value of targeted therapy in times of constrained PPE resources, and the effects of COVID-19 on research activity.
Dr. Rod Page and Dr. Kelly Diehl discuss the origins of the Golden Retriever Lifetime Study, the data trends, and its impact on veterinary medicine.Webinars
FidoCure® stands in solidarity with Black Lives Matter. All businesses, and especially mission driven businesses like ours, must fight abuse of power and social injustice.
In human oncology, there has been a growing focus on analyzing data gathered from routine care, leading to a new field called real world evidence (RWE), which has taken off in recent years. The RWE approaches being used in human oncology can also be applied in the veterinary space.
Telemedicine in veterinary care experienced a boom with the COVID-19 pandemic. As the world shifts to a new normal, Dr. Apryle Horbal joins us to examine the path ahead for telemedicine in veterinary care.Webinars
Telemedicine in veterinary care experienced a boom with the COVID-19 pandemic. Dr. Lance M. Roasa joins us to examine the path ahead for telemedicine in veterinary care.Webinars
Dr. Carrie Jurney highlights the history of mental health in the veterinary community and delves into its effects during the global pandemic.Webinars
One of the first pets to be enrolled in FidoCure®, Forrest, a 11 year-old Golden Retriever diagnosed with hemophagocytic histiocytic sarcoma, illustrates the value of evaluation of exceptional responders.Data
Dr. Gardner discusses some of the scientific and logistical challenges in the genomic analysis of canine cancer during the global pandemic. Dr. Gardner highlights promising areas of research in veterinary oncology, and provides answers to some of your most asked questions.Webinars
In our fifth webinar of this series, we welcome Marcy Bliss, President and CEO of Wedgewood Pharmacy, and Joe Costa, COO of Wedgewood Pharmacy, to discuss the effects of the COVID-19 pandemic on the veterinary compounding pharmaceutical industry.Webinars